INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS

A. S Lysenko; E. S Seliverstov; E. V Zubareva

doi:10.23868/gc122852

Genes & Cells ›› 2020, Vol. 15 ›› Issue (3S) :99 -99. DOI: 10.23868/gc122852

Articles

oration

INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS

A. S Lysenko
, E. S Seliverstov
, E. V Zubareva

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

A. S Lysenko, E. S Seliverstov, E. V Zubareva. INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS. Genes & Cells, 2020, 15(3S): 99-99 DOI:10.23868/gc122852

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	McCubrey J., Steelman L., Bertrand F. et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014; 5(10): 2881-911.

[2]	Domoto T., Pyko I., Furuta T. et al. Glycogen synthase kinase-3p is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 2016; 107(10): 1363-72.